Conference News

ASCO 2023 Omitting Radiation in Rectal Cancer: 'Less Is More' Many patients with locally advanced rectal cancer can skip radiotherapy to the pelvic area, and instead be treated with chemotherapy and then surgery, suggest the results from the PROSPECT trial.
News, June 04, 2023
ASCO 2023 Oral Drug for Brain Tumor Could Change Treatment Landscape In patients with gliomas bearing IDH1/2 mutations, the brain barrier-crossing oral drug vorasidenib kept tumors at bay, and could be used instead of more toxic chemotherapies and radiation.
News, June 04, 2023
ASCO 2023 'Huge Step Forward' in Advanced Ovarian Cancer Adding both durvalumab and olaparib to standard-of-care treatment in newly diagnosed non-BRCA mutated advanced ovarian cancer represents a 'huge step forward,' says one expert.
News, June 03, 2023
EULAR 2023 AI Efforts Make Strides in Predicting Progression to RA Two independent efforts to use artificial intelligence to predict the development of early RA from patients with signs and symptoms not meeting full disease criteria showed good accuracy.
News, June 02, 2023
ASCO 2023 Ribociclib Forestalls Recurrence Also in Early Breast Cancer The combination, known to be effective in metastatic disease, has now also been shown to reduce recurrence in earlier-stage disease when used in combination with endocrine therapy.
News, June 02, 2023
EULAR 2023 Two Biologics Show No Difference in Axial Spondyloarthritis This study represents the first head-to-head trial comparing the effects of two biologics in axial spondyloarthritis, in this case in patients at high risk for radiographic progression.
News, June 01, 2023
EULAR 2023 Lupus Nephritis: Hopes, Questions Arise for Baricitinib Results from a small, independently funded, double-blind, active-comparator trial suggest that baricitinib could be beneficial in the treatment of lupus nephritis.
News, June 01, 2023
EAS 2023 Steep LDL Cholesterol Reductions With ANGPTL3 siRNA in HoFH A single injection every 3 months of a novel drug that targets the lipid metabolism enzyme ANGPTL3 resulted in substantial reductions in LDL cholesterol in patients with HoFH in the phase 2 GATEWAY trial.
News, June 01, 2023
ESOC 2023 Preventive Antipyretics, Antibiotics Not Needed in Stroke Prophylactic use of antiemetic, antipyretic, or antibiotic drugs in older patients with acute stroke did not reduce the risk of a poor functional outcome in the PRECIOUS trial.
News, June 01, 2023
ESOC 2023 Intensive BP Reduction After Stroke Recanalization Harmful Intensive blood pressure management worsens outcomes and should not be pursued in stroke patients successfully recanalized with intra-arterial thrombectomy, results of the OPTIMAL-BP trial show.
News, May 31, 2023
EuroPCR 2023 No Signal of Higher Noncardiac Death With Revascularization Contrary to previous findings, no increased risk of noncardiac mortality was associated with revascularization in a meta-analysis of 18 trials.
News, May 30, 2023
ESOC 2023 Tenecteplase Late After Stroke Misses Endpoint: TIMELESS Giving very late thrombolysis to patients with large-vessel occlusion small core strokes did not show a significant benefit in the TIMELESS trial, although there were some encouraging findings.
News, May 30, 2023
HRS 2023 ECG Monitor Implant Tightens AF Management, Boosts Outcomes Fewer strokes and bleeding complications and greater med compliance were benefits of treatment guided by implanted loop recorders in a registry analysis.
News, May 30, 2023
APA 2023 IV vs Intranasal Ketamine: Which is Best? There is no difference in the efficacy of IV ketamine and its intranasal counterpart for treatment-resistant depression, but cost and the speed of effect may be the factors that determine treatment choice.
News, May 30, 2023
ESOC 2023 Cardiopathy No Basis for Choosing Anticoagulation in ESUS Clinicians shouldn't expect apixaban to offer benefit over aspirin in patients with embolic stroke of undetermined source simply because they have atrial cardiopathy, ARCADIA investigators conclude.
News, May 29, 2023
ESOC 2023 No Added Benefit From Revascularization in Low-Risk CAS Optimized medical therapy may be enough in patients with carotid artery stenosis who have a low to intermediate stroke risk, after the ESCT-2 trial showed no benefit from adding revascularization.
News, May 29, 2023
EAS 2023 Lomitapide Shows Promise in Pediatric Homozygous FH Children and adolescents with homozygous familial hypercholesterolemia could benefit from lomitapide therapy, suggests a trial, although safety concerns and upcoming novel drugs question its place.
News, May 29, 2023
EAS 2023 Overweight in Heterozygous FH Tied to Even Higher CAD Risk The relatively high rates of overweight and obesity among patients with familial hypercholesterolemia should be addressed to reduce apparent impact on coronary artery disease risk, suggests a UK study.
News, May 26, 2023
ESOC 2023 AI Improves Stroke Recognition in Emergency Calls An artificial intelligence tool outperformed human call handlers in recognizing patients with stroke from calls to the emergency services in a new study.
News, May 26, 2023
APA 2023 Music Therapy Helps Motivate Patients With Schizophrenia In addition to reducing negative symptoms of schizophrenia, music therapy improves sleep and symptoms of depression.
News, May 26, 2023

No Results